Katherine E. Price

453 total citations
9 papers, 335 citations indexed

About

Katherine E. Price is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Katherine E. Price has authored 9 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Katherine E. Price's work include Cystic Fibrosis Research Advances (4 papers), Pneumonia and Respiratory Infections (2 papers) and Streptococcal Infections and Treatments (2 papers). Katherine E. Price is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Pneumonia and Respiratory Infections (2 papers) and Streptococcal Infections and Treatments (2 papers). Katherine E. Price collaborates with scholars based in United States. Katherine E. Price's co-authors include Andrew Camilli, George A. O’Toole, Alex H. Gifford, Mitchell L. Sogin, Thomas H. Hampton, Hilary G. Morrison, Emily L. Dolben, Deborah A. Hogan, Neil G. Greene and Walid D. Fakhouri and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Bacteriology.

In The Last Decade

Katherine E. Price

9 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E. Price United States 9 135 131 126 61 53 9 335
Joseph Haynes United States 10 50 0.4× 90 0.7× 94 0.7× 19 0.3× 13 0.2× 27 301
Masamitsu Kono Japan 10 26 0.2× 67 0.5× 218 1.7× 52 0.9× 137 2.6× 51 372
Stavros Panagiotou United Kingdom 9 60 0.4× 24 0.2× 145 1.2× 50 0.8× 156 2.9× 13 369
Katherine Belfield United Kingdom 6 39 0.3× 88 0.7× 50 0.4× 12 0.2× 50 0.9× 9 255
Alexander Tracy United Kingdom 7 80 0.6× 56 0.4× 65 0.5× 19 0.3× 67 1.3× 9 313
Jörg Große-Onnebrink Germany 12 119 0.9× 251 1.9× 43 0.3× 9 0.1× 10 0.2× 21 394
Matthew M. Hewitt United States 7 91 0.7× 115 0.9× 180 1.4× 17 0.3× 17 0.3× 8 507
Paul R. Facemire United States 9 43 0.3× 42 0.3× 103 0.8× 25 0.4× 7 0.1× 17 279
Rahul Gupta United States 7 115 0.9× 22 0.2× 56 0.4× 90 1.5× 27 0.5× 17 355
Yuriko Katsushima Japan 18 257 1.9× 109 0.8× 371 2.9× 15 0.2× 36 0.7× 31 780

Countries citing papers authored by Katherine E. Price

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Price more than expected).

Fields of papers citing papers by Katherine E. Price

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Price. The network helps show where Katherine E. Price may publish in the future.

Co-authorship network of co-authors of Katherine E. Price

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Price. A scholar is included among the top collaborators of Katherine E. Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Price. Katherine E. Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Price, Katherine E., et al.. (2015). Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation. PLoS ONE. 10(10). e0141192–e0141192. 14 indexed citations
2.
Reed, Michael D., David G. C. Hildebrand, Gabrielle Santangelo, et al.. (2015). Assessing contributions of nucleus accumbens shell subregions to reward-seeking behavior. Drug and Alcohol Dependence. 153. 369–373. 11 indexed citations
3.
Price, Katherine E., et al.. (2015). Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Journal of Bacteriology. 198(2). 237–247. 26 indexed citations
4.
Price, Katherine E., et al.. (2015). Analysis of the Relationship between Micrognathia and Cleft Palate: A Systematic Review. The Cleft Palate-Craniofacial Journal. 53(2). 34–44. 15 indexed citations
5.
Gifford, Alex H., Zhigang Li, Lisa A. Moulton, et al.. (2013). Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis. Journal of Cystic Fibrosis. 13(3). 311–318. 25 indexed citations
6.
Price, Katherine E., Thomas H. Hampton, Alex H. Gifford, et al.. (2013). Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome. 1(1). 27–27. 109 indexed citations
7.
Reed, Michael D., et al.. (2012). Predator odor-evoked BOLD activation in the awake rat: Modulation by oxytocin and V1a vasopressin receptor antagonists. Brain Research. 1494. 70–83. 9 indexed citations
8.
Price, Katherine E., Neil G. Greene, & Andrew Camilli. (2012). Export Requirements of Pneumolysin in Streptococcus pneumoniae. Journal of Bacteriology. 194(14). 3651–3660. 40 indexed citations
9.
Price, Katherine E. & Andrew Camilli. (2009). Pneumolysin Localizes to the Cell Wall of Streptococcus pneumoniae. Journal of Bacteriology. 191(7). 2163–2168. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026